Bharat Rekhi Selected Research

Bharat Rekhi Research Topics

Disease

80	Neoplasms (Cancer) 04/2024 - 02/2007
9	Sarcoma (Soft Tissue Sarcoma) 07/2021 - 01/2010
8	Osteosarcoma (Osteogenic Sarcoma) 11/2021 - 01/2013
7	Neoplasm Metastasis (Metastasis) 01/2024 - 10/2007
5	Ewing Sarcoma (Sarcoma, Ewing) 08/2023 - 07/2017
5	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2023 - 09/2012
5	Ovarian Epithelial Carcinoma 10/2022 - 10/2016
5	Chordoma 11/2021 - 08/2010
4	Rhabdomyosarcoma 01/2023 - 05/2014
3	Melanoma (Melanoma, Malignant) 10/2023 - 04/2018
3	Adenocarcinoma 09/2012 - 09/2008
2	Residual Neoplasm 02/2024 - 08/2011
2	Disease Progression 01/2024 - 10/2015
2	Ovarian Neoplasms (Ovarian Cancer) 02/2023 - 01/2021
2	Mesothelioma 10/2022 - 06/2010
2	Pain (Aches) 11/2021 - 01/2013
2	Endometrial Neoplasms (Endometrial Cancer) 08/2020 - 10/2015
2	Synovial Sarcoma (Synovioma) 01/2020 - 12/2013
2	Endometrial Stromal Sarcoma 10/2019 - 10/2014
2	Giant Cell Tumors (Giant Cell Tumor) 01/2017 - 10/2015
2	Leiomyoma (Uterine Fibroids) 07/2015 - 02/2015
1	Fibroma (Fibromatosis) 05/2024
1	Aggressive Fibromatosis (Desmoid) 05/2024
1	Extranodal Extension 01/2024
1	Virus Diseases (Viral Diseases) 01/2023
1	Primitive Neuroectodermal Tumors (PNET) 01/2022
1	Chondrosarcoma 11/2021
1	Pseudarthrosis (Pseudoarthrosis) 05/2021
1	Tuberculosis (Tuberculoses) 04/2021
1	Anemia 01/2021

Drug/Important Bio-Agent (IBA)

22	Keratins (Keratin)IBA 04/2024 - 03/2007
18	DesminIBA 01/2024 - 03/2011
13	VimentinIBA 12/2021 - 02/2007
13	Mucin-1 (CA 15-3 Antigen)IBA 12/2021 - 03/2010
9	SynaptophysinIBA 01/2022 - 03/2010
8	S100 Proteins (S 100 Protein)IBA 12/2021 - 08/2010
7	MyogeninIBA 01/2023 - 12/2011
7	Brachyury protein (Brachyury)IBA 12/2021 - 08/2010
6	ParaffinIBA 10/2023 - 12/2011
5	Estrogen ReceptorsIBA 10/2023 - 07/2012
5	Methotrexate (Mexate)FDA LinkGeneric 01/2019 - 04/2016
5	ChromograninsIBA 10/2015 - 03/2010
4	ChromatinIBA 01/2023 - 11/2013
4	Ifosfamide FDA LinkGeneric 01/2022 - 11/2017
4	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 11/2017
4	MART-1 AntigenIBA 08/2017 - 12/2011
4	Progesterone Receptors (Progesterone Receptor)IBA 11/2015 - 07/2012
3	Denosumab FDA Link 02/2024 - 01/2017
3	Formaldehyde (Formol)FDA Link 10/2023 - 12/2013
3	Calbindin 2IBA 08/2023 - 07/2010
3	Biomarkers (Surrogate Marker)IBA 02/2023 - 02/2020
3	AntigensIBA 02/2023 - 04/2018
3	Paclitaxel (Taxol)FDA LinkGeneric 01/2022 - 01/2020
3	PlatinumIBA 01/2022 - 01/2020
3	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 11/2017
3	Proteins (Proteins, Gene)FDA Link 08/2020 - 10/2015
3	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2020 - 11/2017
3	Phosphopyruvate Hydratase (Enolase)IBA 02/2013 - 03/2010
2	Calmodulin-Binding Proteins (Caldesmon)IBA 01/2023 - 03/2011
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022 - 01/2021
2	Vincristine (Oncovin)FDA LinkGeneric 01/2022 - 01/2021
2	Etoposide (VP 16)FDA LinkGeneric 01/2022 - 01/2021
2	Cyclin D1IBA 10/2019 - 10/2014
2	Fluorine-18IBA 06/2019 - 04/2015
2	Transcription Factors (Transcription Factor)IBA 12/2016 - 08/2010
2	Keratin-7 (Cytokeratin 7)IBA 10/2015 - 09/2008
2	CalponinsIBA 07/2014 - 12/2011
2	Melanins (Melanin)IBA 07/2012 - 08/2011
1	Aggrecans (Aggrecan)IBA 02/2024
1	Everolimus FDA Link 01/2024
1	TOR Serine-Threonine KinasesIBA 01/2024
1	pyridinium 3-methoxyestra-1,3,5(10)-trien-6-yl sulfate (PMTS)IBA 11/2023
1	Neurofibromin 1 (Neurofibromin)IBA 10/2023
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 10/2023
1	Keratin-1IBA 08/2023
1	KIR ReceptorsIBA 01/2023
1	1-methyl-1-piperidinomethane sulfonateIBA 10/2022
1	AnthracyclinesIBA 02/2022
1	Gemcitabine FDA Link 02/2022
1	Insulin-Like PeptidesIBA 01/2022
1	GlypicansIBA 12/2021
1	Interleukin-6 (Interleukin 6)IBA 08/2021
1	pazopanib FDA Link 07/2021
1	Genetic Markers (Genetic Marker)IBA 07/2021
1	Tumor Biomarkers (Tumor Markers)IBA 04/2021
1	Immune Checkpoint InhibitorsIBA 01/2021

Therapy/Procedure

16	Drug Therapy (Chemotherapy) 08/2023 - 01/2013
10	Therapeutics 05/2024 - 02/2013
8	Hysterectomy 01/2024 - 12/2011
8	Radiotherapy 01/2022 - 08/2011
4	Neoadjuvant Therapy 01/2021 - 01/2013
4	Combination Drug Therapy (Combination Chemotherapy) 01/2021 - 11/2017
3	Salpingo-oophorectomy 01/2024 - 10/2015
2	Adjuvant Chemotherapy 01/2024 - 12/2022
2	Adjuvant Radiotherapy 08/2023 - 07/2015
2	Operative Surgical Procedures 07/2021 - 01/2017
1	Cytoreduction Surgical Procedures 01/2024
1	Palliative Care (Palliative Therapy) 02/2022
1	Nephrectomy 12/2021
1	Hemipelvectomy 05/2021